MARK VERSAVEL is listed as an executive officer on 3 SEC Form D filings by 1 issuer between Jul 2013 and Jan 2015: ALZHEON, INC. (Framingham, MA — biotechnology — 2013–2015; $126.3M reported sold to 81 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside John Hey (3 shared filings), MARTIN TOLAR (3 shared filings), ADAM HALE BROCKMAN (2 shared filings), GREGORY LEON MILLER (2 shared filings), JEREMY YONGXIN YU (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around MARK. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for MARK VERSAVEL and found 3 differences, 1 worth asking the sponsor about: MARK VERSAVEL is no longer listed on the Feb 25, 2015 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.